Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.210
+0.100 (2.43%)
At close: Sep 11, 2026, 4:00 PM EDT
4.050
-0.160 (-3.80%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Alterity Therapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Alterity Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $13.25. The average 1-year stock price forecast is 214.73% higher than the current stock price, while the lowest is $10 (+137.53%) and the highest is $16 (+280.05%).
Price Target: $13.25 (+214.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alterity Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $16 | Buy | Maintains | $16 | +280.05% | Aug 28, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Initiates $12 | Buy | Initiates | $12 | +185.04% | Aug 11, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $10 | Buy | Initiates | $10 | +137.53% | Jun 16, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $12 | Buy | Reiterates | $12 | +185.04% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
537.52K
from 3.61M
Decreased by -85.11%
Revenue Next Year
2.17M
from 537.52K
Increased by 304.56%
EPS This Year
-1.60
from -0.10
EPS Next Year
-1.62
from -1.60
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.